Cefuroxime
CEFUROXIME FOR INJECTION, USP
Approved
Approval ID
703cc338-c0b6-4a02-b8db-c27aeff181df
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Apr 8, 2020
Manufacturers
FDA
Hikma Pharmaceuticals USA Inc.
DUNS: 001230762
Products 2
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Cefuroxime
PRODUCT DETAILS
NDC Product Code0143-9977
Application NumberANDA065048
Marketing CategoryC73584
Route of AdministrationINTRAVENOUS
Effective DateApril 8, 2020
Generic NameCefuroxime
INGREDIENTS (1)
CEFUROXIME SODIUMActive
Quantity: 1.5 g in 1 1
Code: R8A7M9MY61
Classification: ACTIM
Cefuroxime
PRODUCT DETAILS
NDC Product Code0143-9979
Application NumberANDA065048
Marketing CategoryC73584
Route of AdministrationINTRAMUSCULAR, INTRAVENOUS
Effective DateApril 8, 2020
Generic NameCefuroxime
INGREDIENTS (1)
CEFUROXIME SODIUMActive
Quantity: 750 mg in 1 1
Code: R8A7M9MY61
Classification: ACTIM